Matthew E. Barton

1.3k total citations
28 papers, 1.0k citations indexed

About

Matthew E. Barton is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew E. Barton has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 9 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew E. Barton's work include Gastrointestinal motility and disorders (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Diet and metabolism studies (5 papers). Matthew E. Barton is often cited by papers focused on Gastrointestinal motility and disorders (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Diet and metabolism studies (5 papers). Matthew E. Barton collaborates with scholars based in United States, United Kingdom and Belgium. Matthew E. Barton's co-authors include H. Steve White, Harold H. Wolf, Brian D. Klein, Harlan E. Shannon, Steven Peters, Karen S. Wilcox, George E. Dukes, Elizabeth L. Eberle, H E Shannon and Duncan Richards and has published in prestigious journals such as Gastroenterology, Diabetes and Neuroscience.

In The Last Decade

Matthew E. Barton

26 papers receiving 1.0k citations

Peers

Countries citing papers authored by Matthew E. Barton

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Barton more than expected).

Fields of papers citing papers by Matthew E. Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Barton. The network helps show where Matthew E. Barton may publish in the future.

Co-authorship network of co-authors of Matthew E. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew E. Barton. A scholar is included among the top collaborators of Matthew E. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew E. Barton. Matthew E. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Update on the TOGETHER study: a patient‐ and investigator‐blind, randomized, placebo‐controlled study evaluating the efficacy, safety and tolerability of bepranemab, UCB0107, in prodromal‐to‐mild Alzheimer’s disease 2022 ·Alzheimer s & Dementia ·Matthew E. Barton, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Colin J. Ewen	3
2	Total body skeletal muscle mass estimated by magnetic resonance imaging and creatine (methyl‐d₃) dilution in athletes 2019 ·Scandinavian Journal of Medicine and Science in Sports ·(unknown), Stephen A. Stimpson, Ram R. Miller, Matthew E. Barton, Michael S. Leonard, Owen Carmichael, Ken A. van Someren, Stephen D. R. Harridge	9
3	Manometric evaluation of the motilin receptor agonist camicinal (GSK962040) in humans 2017 ·Neurogastroenterology & Motility ·Eveline Deloose, Inge Depoortere, Jan de Hoon, A. Van Hecken, Odile Dewit, (unknown), Matthew E. Barton, George E. Dukes, Jan Tack	9
4	The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying 2016 ·British Journal of Pharmacology ·Per M. Hellström, Jan Tack, (unknown), Kimberley Hacquoil, Matthew E. Barton, Duncan Richards, David Alpers, Gareth J. Sanger, George E. Dukes	27
5	The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial 2016 ·Critical Care ·Marianne J. Chapman, Adam M. Deane, Stephanie O’Connor, Nam Q. Nguyen, Robert Fraser, Duncan Richards, Kimberley Hacquoil, (unknown), Matthew E. Barton, George E. Dukes	28
6	The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial 2015 ·Neurogastroenterology & Motility ·Ruth M. Hobson, Adam D. Farmer, Odile Dewit, Matthew O’Donnell, Kimberley Hacquoil, Darren Robertson, Matthew E. Barton, George E. Dukes	15
7	Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects 2015 ·Clinical Pharmacology in Drug Development ·Herbert Struemper, (unknown), Jane Gilbert, Matthew E. Barton, (unknown), James Groark, Norma Lynn Fox, David A. Roth, David Gordon	26
8	70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis 2014 ·Gastroenterology ·Matthew E. Barton, (unknown), (unknown), Darren Robertson, Robert L. Dobbins, Henry P. Parkman, Per M. Hellström, Jan Tack, Braden Kuo, Anthony Hobson, George E. Dukes	27
9	Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742 2008 ·Inflammation Research ·Zdenka Hašková, Bao Hoang, Guo-Lun Luo, Lisa Morgan, Andrew N. Billin, (unknown), (unknown), Matthew E. Barton, Kenneth S. Kilgore	40
10	Inhibition of Phosphodiesterase Type 4 Decreases Stress-Induced Defecation in Rats and Mice 2007 ·Pharmacology ·Frank C. Barone, Matthew E. Barton, Ray F. White, Jeffrey J. Legos, Hideo Kikkawa, (unknown), (unknown), Mine Kinoshita	20
11	Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds 2007 ·Epilepsy Research ·Jeffrey M. Witkin, Melvyn Baez, (unknown), Matthew E. Barton, Harlan E. Shannon	35
12	Behavioral and convulsant effects of the (S) enantiomer of the group I metabotropic glutamate receptor agonist 3,5-DHPG in mice 2005 ·Neuropharmacology ·Matthew E. Barton, Harlan E. Shannon	15
13	The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil 2005 ·European Journal of Pharmacology ·Matthew E. Barton, Elizabeth L. Eberle, Harlan E. Shannon	46
14	The seizure-related phenotype of brain-derived neurotrophic factor knockdown mice 2005 ·Neuroscience ·Matthew E. Barton, H E Shannon	24
15	The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression 2004 ·Epilepsy Research ·Matthew E. Barton, H. Steve White	28
16	The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs 2004 ·Epilepsy Research ·Matthew E. Barton, H. Steve White, Karen S. Wilcox	37
17	Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models 2003 ·Epilepsy Research ·Matthew E. Barton, Steven Peters, Harlan E. Shannon	91
18	Anticonvulsant Profile and Teratogenicity of N‐methyl‐tetramethylcyclopropyl Carboxamide: A New Antiepileptic Drug 2002 ·Epilepsia ·Nina Isoherranen, H. Steve White, Richard H. Finnell, Boris Yagen, José H. Woodhead, Gregory D. Bennett, Karen S. Wilcox, Matthew E. Barton, Meir Bialer	25
19	Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy 2001 ·Epilepsy Research ·Matthew E. Barton, Brian D. Klein, Harold H. Wolf, H. Steve White	474
20	Dünndarmileus bei intestinalem Marginalzonen-B-Zell-Lymphom des MALT 2001 ·DMW - Deutsche Medizinische Wochenschrift ·Martin Brueck, Matthew E. Barton, K. Rauber, (unknown), William G. Kramer	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact